课题基金 / 基金详情

Comprehensive pathway generation of drug action and drug metabolism for DrugBank

Comprehensive pathway generation of drug action and drug metabolism for DrugBank
DrugBank 药物作用和药物代谢的综合路径生成
批准号:
565707-2021
负责人:
Wishart, David
金额:
$5.7万
依托单位:
依托单位国家:
加拿大
项目类别:
Alliance Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-01-01 至 2022-12-31

项目摘要

项目成果

Wishart, David的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DrugBank is a comprehensive, freely available web resource containing detailed drug action and metabolism information for ~3000 medically approved drugs. It is accessed by 1000s of scientists and millions of students, teachers, pharmacists and consumers each year. It is widely used both as a teaching tool and a drug discovery platform. To make DrugBank more appealing to a wider audience, we have started generating detailed diagrams (pathways) illustrating how different drugs work and how they are metabolized in the body. These pathways depict complex molecular processes using colourful, carefully designed molecular maps filled with scientifically accurate details. To date we have drawn and annotated nearly 450 drug action and drug metabolism pathways. Our goal for this project is to illustrate another 2500 pathways so that nearly every drug in DrugBank has a pathway. Generating a single drug pathway requires hours of extensive literature research by knowledgeable individuals with training in medicinal chemistry, pharmacy and/or biochemistry. It also requires many hours of skillful, strictly standardized illustration by pathway artists. The pathways are generated using a specially developed program called PathWhiz that allows pathways to be drawn directly on the computer and saved in a computer-readable format. When this project is complete, DrugBank will have the world's largest collection of drug action and drug metabolism pathways. These pathways will be made publicly available and will provide a superb resource for Canadian students, teachers, pharmacists, consumers or anyone wanting to know more about drugs and drug action. More importantly, by creating thousands of computer-readable pathways, this project will allow data scientists to systematically mine, compare, extract and interpret the information in DrugBank's pathways. This will lead to a fundamentally better understanding of drug action and could potentially inspire the development of new drugs. Indeed, the creation and use of pathway databases in both biochemistry and genetics has revolutionized both fields. We believe the creation of a drug pathway database could do the same for the Canadian drug industry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Approaches to Spectral Prediction and Spectral Deconvolution for Metabolomics
  • 批准号:
    RGPIN-2019-05538
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $5.76万
  • 财政年份:
    2022
  • 负责人:
    Wishart, David
  • 依托单位:
Novel Approaches to Spectral Prediction and Spectral Deconvolution for Metabolomics
  • 批准号:
    RGPIN-2019-05538
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $5.76万
  • 财政年份:
    2021
  • 负责人:
    Wishart, David
  • 依托单位:
Novel Approaches to Spectral Prediction and Spectral Deconvolution for Metabolomics
  • 批准号:
    RGPIN-2019-05538
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $5.76万
  • 财政年份:
    2020
  • 负责人:
    Wishart, David
  • 依托单位:
Novel Approaches to Spectral Prediction and Spectral Deconvolution for Metabolomics
  • 批准号:
    RGPIN-2019-05538
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $5.76万
  • 财政年份:
    2019
  • 负责人:
    Wishart, David
  • 依托单位:
国内基金
海外基金
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位:
肠道菌群介导的脱氧胆酸激活S1PR2/NLRP3/IL-1β通路在炎症性肠病合并艰难梭菌感染中的致病机制研究
  • 批准号:
    82372306
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    彭奕冰
  • 依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
  • 批准号:
    82371726
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    李文
  • 依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
  • 批准号:
    82371652
  • 项目类别:
    面上项目
  • 资助金额:
    45.00万元
  • 批准年份:
    2023
  • 负责人:
    刘开江
  • 依托单位: